Centers | ||
FDA Oncology Center of Excellence Project Catalyst | Experimental Pharmacology Laboratory | Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) |
Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation |
The University of Cyprus Experimental Pharmacology Laboratory is a molecular and behavioural pharmacology laboratory based in the Medical School of the University of Cyprus. Read moreOur research revolves around novel drug discovery and drug repurposing... |
The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... |
Partnerships |
Events |
Jobs |
Sanofi to Collaborate with UCSF to Develop New Drugs to Treat DiabetesUniversity of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology expertise at Sanofi will be partnering with... View all JDRF & Novo Nordisk to Collaborate on Type 1 DiabetesJDRF and Novo Nordisk have entered into collaboration to develop new immunotherapies to treat Type 1 diabetes. The new partnership will be based out of Novo's newly opened Type 1 Diabetes R&D Center in Seattle. JDRF and Novo Nordisk will be... View all Johns Hopkins BSi Licenses GCPII Assets from EisaiJohns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted... View all |
No EVENTS for listing |
No Job Posts |


